NDC11 62032012210

This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.

Possible FDA NDC forms#

Package NDC, Product root table
Package NDC	Product root
62032-0122-10	62032-0122
62032-122-10	62032-122

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Obagi-C C-Rx system Normal-oily skin Intervention	HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE	Obagi Cosmeceuticals LLC	a9ceacb3-d6e4-4316-a4e9-f15e574cdda0	2025-11-13	Warnings	Exact identifier ndc (package): 62032-122-10 ndc11 (package): 62032012210
Obagi-C C-Rx System Normal-Oily Skin Intervention	HYDROQUINONE, HOMOSALATE, OCTISALATE, ZINC OXIDE	Obagi Cosmeceuticals LLC	e19b824f-4438-48c8-af4c-29be197f9cdc	2025-10-21	Warnings	Exact identifier ndc (package): 62032-122-10 ndc11 (package): 62032012210
OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C	HYDROQUINONE	Obagi Cosmeceuticals LLC	18803dfb-5b9c-48cd-a838-519c8bac3361	2020-06-02	Warnings, Adverse reactions	Exact identifier ndc (package): 62032-122-10 ndc (product): 62032-122 ndc11 (package): 62032012210

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.